EMJ Podcast: Insights For Healthcare Professionals

In this episode of Onc Now, Stephen Chan, Clinical Professor in the Department of Clinical Oncology at The Chinese University of Hong Kong, explores the evolving landscape of hepatobiliary and pancreatic cancers. From advances in translational science and precision therapies to the challenges of neuroendocrine tumour care, Chan reflects on the progress made in oncology and the breakthroughs still needed. He also discusses his work with the Hand-in-Hand Cancer Foundation, highlighting the importance of education, compassion, and holistic support for patients and their families.

Timestamps:

00:00 – Introduction

01:18 - Current Hepatobiliary and Pancreatic Landscape

03:23 - Translational Science and Patient Outcomes

05:06 - Founding the Hand-in-Hand Cancer Foundation

06:53 - Advances in Precision Cancer Therapies

08:54 – Rising Incidence of Pancreatic Cancer Post COVID-19

10:45 - President of the International Liver Cancer Association

12:46 - Challenges in Neuroendocrine Tumour Care

14:32 - Future Breakthroughs in Cancer Care

16:02 - Three Wishes for Oncology's Future

This podcast was developed by AMJ in collaboration with GSK and is sponsored by GSK. This information is scientific and non-promotional in nature, and intended for US audiences.

Less than 20% of biologic-eligible patients with GINA Step 5 asthma receive biologic therapy.1,2 In this AMJ podcast, experts discuss how real-world gaps in initiation, access, and adherence can affect whether patients start, stay on, and sustain benefit from biologic therapy over time.

Listen to the full episode to explore:

• Key real-world data on biologic initiation and adherence in severe asthma
• Patient cases showing common barriers across the care pathway
• Practical ways to uncover the burden of severe asthma
• The Start, Stay, Sustain framework for patient-centered care

Speakers:

• Justin Kwiatek, US Medical Affairs Lead, Respiratory Biologics, GSK
• Tom Corbridge, US Senior Medical Director, Respiratory Biologics, GSK

References

1. Park J et al. Biologic underutilization and healthcare burden in US patients with Type 2 severe asthma. J Asthma Allergy. 2026;19:580937.
2. Maselli DJ et al. Patient characteristics and social determinants of health influence adherence to biologic therapy for asthma. SEAAIS 80th Annual Meeting, October 23-26, 2025.

Sharonne N. Hayes joins host Saranya Ravindran to discuss how cardiovascular disease presents differently in women. From pregnancy-related complications and menopause to microvascular disease and gaps in clinician education, this episode explores the importance of sex-specific cardiovascular care.

Timestamps:

1:04 – Sex-specific differences

2:43 – Pregnancy and preeclampsia

4:38 – Historic underdiagnosis

7:00 – Menopause and hormones

10:04 – Education and training

In this rapid-fire episode, Sharonne N. Hayes answers key questions on women's cardiovascular health, SCAD, unconscious bias, prevention, and the future of equitable heart care. A concise, expert-led overview of the field.

In the final episode, Bryan Tucker explores the future of kidney stone prevention and treatment. From genetics and microbiome research to wearable hydration technology and AI-driven risk prediction, this episode examines how personalised medicine could transform nephrolithiasis care over the next decade.

Timestamps:

01:01 – Future changes in kidney stone care

04:21 – Microbiome and stone risk

05:34 – AI-driven risk prediction

07:02 – Ideal future of care

In Part 2, Bryan Tucker discusses the balance between acute intervention and long-term prevention in kidney stone care. Learn why many patients never receive comprehensive metabolic evaluation, how healthcare systems prioritise procedures over prevention, and what changes are needed to improve recurrence prevention.

Timestamps:

01:05 – Intervention and long-term prevention

04:01 – Gaps in follow-up evaluations

06:57 – Care changes for better prevention

This podcast has been funded by an educational grant from Viatris.

Systemic lupus erythematosus (SLE) is a complex, heterogeneous disease shaped by dysregulated immune pathways, variable organ involvement, and substantial patient burden. In this educational podcast, Anca Askanase explores how a deeper understanding of SLE immunology can help rheumatologists contextualize disease activity, evolving research, and guideline-based care.

Topics covered:

• Key immune pathways involved in SLE pathophysiology, including innate and adaptive immune dysregulation
• How pathway biology may help explain clinical heterogeneity and differences in disease activity between patients
• What rheumatologists should consider when interpreting emerging pathway-based research and cross-disease immunology concepts
• How current guideline-based care frames treatment goals, patient burden, and the evolving focus on remission in SLE

Speakers

Anca D. Askanase, Chair, Department of Medicine, and Chief, Division of Rheumatology, Hospital for Special Surgery, New York, USA

In this episode of Hema Now, we speak with Cecilia Karlström about advances in rare and complex haematological disorders. She discusses the evolving understanding of platelet refractoriness and transfusion support, the challenges in diagnosing systemic mastocytosis, and how targeted therapies are reshaping outcomes in rare blood diseases. The conversation also explores the growing role of precision medicine, multidisciplinary care, and future priorities in haematology research.

Timestamps:

00:00 – Introduction

01:21 – Career inspiration in haematology origins

02:43 – Evolution of platelet refractoriness management

03:39 – Current state systemic mastocytosis care

05:03 – Diagnosing systemic mastocytosis challenges today

07;26 – Impact of targeted therapies mastocytosis

07:26 – Future precision medicine opportunities haematology

09:00 – Multidisciplinary care improving patient outcomes

10:25 – Improving equity rare disease access

11:43 – Exciting research areas haematological disorders

13:14 – Three wishes future haematology advances

Bryan Tucker joins host Catherine Glass to explore why kidney stone disease is becoming increasingly common worldwide. From dietary and metabolic drivers to male predominance and prevention strategies, this episode examines how nephrolithiasis reflects broader shifts in metabolic health and lifestyle.

Timestamps:

01:13 – Increased prevalence

03:19 – Metabolic issues

04:30 – Increased prevalence in men

06:50 – Population-level prevention strategies

08:24 – Cardiometabolic syndrome

In this rapid-fire episode, Bryan Tucker answers key questions about kidney stone disease, from common myths and overlooked risk factors to hydration, prevention, and emerging technologies. Perfect for listeners short on time but looking for expert insights into the future of nephrolithiasis care.